Substance
Ivacaftor
Global reference: every product and company linked to this substance.
- cas: 873054-44-5
- ncit: C166523
- pubchem_cid: 16220172
- rxnorm: 1243041
- unii: 1Y740ILL1Z
Ivacaftor [INN] · Ivacaftor [USAN] · Ivacaftor [WHO-DD] · Kalydeco · ORKAMBI COMPONENT IVACAFTOR · SYMKEVI COMPONENT IVACAFTOR · TRIKAFTA COMPONENT IVACAFTOR · VX-770
Revenue by company (1)
| Company | Latest period | Revenue |
|---|---|---|
| Vertex Pharmaceuticals Incorporated Common Stock | Q2 2026 | $10.0B* |
Revenue is reported per filer and is never summed across companies here.
Products containing this substance (17)
- KALYDECO · Vertex Pharmaceuticals Incorporated Common Stock
- KALYDECO · Vertex Pharmaceuticals Incorporated Common Stock
- KALYDECO · Vertex Pharmaceuticals Incorporated Common Stock
- KALYDECO · Vertex Pharmaceuticals Incorporated Common Stock
- KALYDECO · Vertex Pharmaceuticals Incorporated Common Stock
- KALYDECO · Vertex Pharmaceuticals Incorporated Common Stock
- ORKAMBI · Vertex Pharmaceuticals Incorporated Common Stock
- ORKAMBI · Vertex Pharmaceuticals Incorporated Common Stock
- ORKAMBI · Vertex Pharmaceuticals Incorporated Common Stock
- ORKAMBI · Vertex Pharmaceuticals Incorporated Common Stock
- ORKAMBI · Vertex Pharmaceuticals Incorporated Common Stock
- SYMDEKO (COPACKAGED) · Vertex Pharmaceuticals Incorporated Common Stock
- SYMDEKO (COPACKAGED) · Vertex Pharmaceuticals Incorporated Common Stock
- TRIKAFTA (COPACKAGED) · Vertex Pharmaceuticals Incorporated Common Stock
- TRIKAFTA (COPACKAGED) · Vertex Pharmaceuticals Incorporated Common Stock
- TRIKAFTA (COPACKAGED) · Vertex Pharmaceuticals Incorporated Common Stock
- TRIKAFTA (COPACKAGED) · Vertex Pharmaceuticals Incorporated Common Stock